0Senior Physician or Specialist in Oncological Studies - Department of Medicine (m/f/d)
Universitätsklinikum Tübingen | Germany | 72xxx Tübingen | Temporary contract | Part time - flexible / Full time / Home office | Published since: 03.02.2026 on stepstone.de

Senior Physician or Specialist in Oncological Studies - Department of Medicine (m/f/d)

Branch: Public relations Branch: Public relations


The University Hospital Tübingen is a leading center of German university medicine. Around 75,000 patients become stationary and approx. 380,000 outpatiently treated. With around 10,600 employees, it is the largest employer in the region. The quality of the medical care is certified with the quality seal of the KTQ. About the department The National Center for Tumor Diseases (NCT Southwest, Tübingen site) in conjunction with the Department of Internal Medicine VIII, Medical Oncology and Pneumology, is looking for test physicians / Principal Investigator / Sub-Investigator for early oncological studies. In our NCT Clinical Trial Center (CTC) and in our Early Clinical Trial Unit (ECTU), a wide range of clinical studies focusing on molecular tumor therapies and immune therapies are conducted. Senior Physician or specialist oncological studies (w/m/d) Medical University Hospital, National Center for Tumor Diseases and Medical Oncology and Pneumology, Kennz. 7231 Working time: 50-100 % | Period: 2 years 1 | Working time: 01.04.2026 | Application deadline: 28.02.2026 | TV-A i.d.R. Ä2-Ä3 2

Your tasks • Your profile • What we offer

The University Hospital Tübingen is a leading center of German university medicine. Around 75,000 patients become stationary and approx. 380,000 outpatiently treated. With around 10,600 employees, it is the largest employer in the region. The quality of the medical care is certified with the quality seal of the KTQ. About the department The National Center for Tumor Diseases (NCT Southwest, Tübingen site) in conjunction with the Department of Internal Medicine VIII, Medical Oncology and Pneumology, is looking for test physicians / Principal Investigator / Sub-Investigator for early oncological studies. In our NCT Clinical Trial Center (CTC) and in our Early Clinical Trial Unit (ECTU), a wide range of clinical studies focusing on molecular tumor therapies and immune therapies are conducted. Senior Physician or specialist oncological studies (w/m/d) Medical University Hospital, National Center for Tumor Diseases and Medical Oncology and Pneumology, Kennz. 7231 Working time: 50-100 % | Period: 2 years 1 | Working time: 01.04.2026 | Application deadline: 28.02.2026 | TV-A i.d.R. Ä2-Ä3 2

Conduct oncological studies with innovative active substances (according to ICH-GCP guidelines) Active role in recruiting students; Participation in the tumor boards including the molecular tumor board of the UKT Active role in designing new studies including interaction with patient representatives

Specialist in Internal Medicine, Haematology and Oncology or Specialist in Internal Medicine or Specialist Career (Test is filed within one year) Experience in clinical research desirable, but no condition High team capability, flexibility and durability Very good communication skills in German & English (written + oral)

A responsible position in our top-class oncological centre with possibility to participate in national/international congresses and test medical meetings. Modern environment: Innovative university clinic, state-of-the-art technology, international top research, excellent perspectives Career & Development: Structured incorporation, hospital-owned academy, diverse training offers, targeted career promotion Work-Life-Balance: Flexible working time models, Mobile working options, Operational daycare, Long-term account & Business days (TV UK) Sensual work: Contribution to the improved quality of life of people Research: top-level research, promotion from PhD to professorship

Location

ava Universitätsklinikum Tübingen
Geissweg 5, 72076  Tübingen
Germany

The text of this ad was translated from German into English using an automatic translation system and may contain semantic and lexical errors. Therefore, it should be used for introductory purposes only. For more detailed information, see the original text of the ad at the link below.

For more information read the original ad

Permanent link to this ad

Ad Id